Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Additionally, children with optimal immune recovery recorded higher proportion of vitamin D deficiency and insufficiency (12.24% and 42.86%) as compared with sub optimally recovered 1.02% and 4.08%); while children with optimal viral suppression recorded higher proportion of vitamin D deficiency and insufficiency (8.16% and 30.61%) as compared with sub optimally suppressed (5.1% and 16.3%).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

We performed a cross-sectional study of 196 participants aged 3 to 14 years; among them 98 HIV infected who received treatment between 2019 to 2020 in Jaramogi Oginga Odinga Teaching and Referral Hospital, Kenya.

Source: Abstract.

We performed a cross-sectional study of 196 participants aged 3 to 14 years; among them 98 HIV infected who received treatment between 2019 to 2020 in Jaramogi Oginga Odinga Teaching and Referral Hospital, Kenya.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

The role of vitamin D status on treatment outcome among HIV: infected children receiving care in Kisumu County, Kenya

Cross-sectional study · Research Square · 2023

Original publication title

The role of vitamin D status on treatment outcome among HIV: infected children receiving care in Kisumu County, Kenya

Maurice Songoreh Asamuka; Lilian Ogonda; Calleb George Onyango; Bernard Guyah

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Infections with HIV suppresses levels of vitamin D, but this has no influence on CD4 counts and viral load status in children receiving ART.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Kenya has a paediatric HIV burden of nearly 140,000 children, of which only 48% of those on antiretroviral therapy (ART) have achieved the desired viral suppression possibly due to vitamin D deficiency. We explored the influence of vitamin D levels on treatment outcome.

Source: Background:

Abstract: What methods does the paper describe?

We performed a cross-sectional study of 196 participants aged 3 to 14 years; among them 98 HIV infected who received treatment between 2019 to 2020 in Jaramogi Oginga Odinga Teaching and Referral Hospital, Kenya. The exposure was vitamin D levels, including deficient (<20 ng/ml), insufficient (≥20: <30 ng/ml), and sufficient (30 to 50ng/ml). The outcome was optimal immune recovery (CD4 ≥ 500 cells/mm3) and optimal viral suppression (viral load ≤ 200 copies/ml). We compared difference in means for each vitamin D category between HIV infected and uninfected using independent t-test, multiple comparisons of vitamin D levels among age categories using ANOVA and post hoc test and Pearson correlation to correlate vitamin D levels, CD4 and viral load of HIV infected children.

Source: Method:

Abstract: Results

Compared with HIV uninfected, HIV infected recorded mean age ± standard deviation of10.65±2.17 years with 39(39.8%) males vs. 6.68±2.81 years with 52(53.1%) males p<0.001; and the difference in vitamin D mean levels was statistically significant [28.21 ± 6.39 infected vs.30.88 ± 6.62 uninfected] t = 2.94, df =194, p = 0.004, 95%CI (0.90 to 4.59). Among age categories, mean vitamin D varied significantly F (2,193) = 10.68, p =0.001; with higher levels observed between 1 to 4 years category {mean difference 4.64ng/ml, p = 0.02, [95%CI 1.49 to 7.78]} and 5 to 9 years category {mean difference 4.33ng/ml, p = 0.001, [95%CI 1.89 to 6.38]} as compared to 10 to 14 years respectively.

Additionally, children with optimal immune recovery recorded higher proportion of vitamin D deficiency and insufficiency (12.24% and 42.86%) as compared with sub optimally recovered 1.02% and 4.08%); while children with optimal viral suppression recorded higher proportion of vitamin D deficiency and insufficiency (8.16% and 30.61%) as compared with sub optimally suppressed (5.1% and 16.3%).

Source: Results: Source: Results:

Abstract: Conclusion

Infections with HIV suppresses levels of vitamin D, but this has no influence on CD4 counts and viral load status in children receiving ART.

Source: Conclusion:
Authors’ abstract

Background:

Kenya has a paediatric HIV burden of nearly 140,000 children, of which only 48% of those on antiretroviral therapy (ART) have achieved the desired viral suppression possibly due to vitamin D deficiency. We explored the influence of vitamin D levels on treatment outcome.

Method:

We performed a cross-sectional study of 196 participants aged 3 to 14 years; among them 98 HIV infected who received treatment between 2019 to 2020 in Jaramogi Oginga Odinga Teaching and Referral Hospital, Kenya. The exposure was vitamin D levels, including deficient (<20 ng/ml), insufficient (≥20: <30 ng/ml), and sufficient (30 to 50ng/ml). The outcome was optimal immune recovery (CD4 ≥ 500 cells/mm3) and optimal viral suppression (viral load ≤ 200 copies/ml). We compared difference in means for each vitamin D category between HIV infected and uninfected using independent t-test, multiple comparisons of vitamin D levels among age categories using ANOVA and post hoc test and Pearson correlation to correlate vitamin D levels, CD4 and viral load of HIV infected children.

Results:

Compared with HIV uninfected, HIV infected recorded mean age ± standard deviation of10.65±2.17 years with 39(39.8%) males vs. 6.68±2.81 years with 52(53.1%) males p<0.001; and the difference in vitamin D mean levels was statistically significant [28.21 ± 6.39 infected vs.30.88 ± 6.62 uninfected] t = 2.94, df =194, p = 0.004, 95%CI (0.90 to 4.59). Among age categories, mean vitamin D varied significantly F (2,193) = 10.68, p =0.001; with higher levels observed between 1 to 4 years category {mean difference 4.64ng/ml, p = 0.02, [95%CI 1.49 to 7.78]} and 5 to 9 years category {mean difference 4.33ng/ml, p = 0.001, [95%CI 1.89 to 6.38]} as compared to 10 to 14 years respectively.

Additionally, children with optimal immune recovery recorded higher proportion of vitamin D deficiency and insufficiency (12.24% and 42.86%) as compared with sub optimally recovered 1.02% and 4.08%); while children with optimal viral suppression recorded higher proportion of vitamin D deficiency and insufficiency (8.16% and 30.61%) as compared with sub optimally suppressed (5.1% and 16.3%).

Conclusion:

Infections with HIV suppresses levels of vitamin D, but this has no influence on CD4 counts and viral load status in children receiving ART.

Publication and source details

Original title: The role of vitamin D status on treatment outcome among HIV: infected children receiving care in Kisumu County, Kenya

Maurice Songoreh Asamuka; Lilian Ogonda; Calleb George Onyango; Bernard Guyah

Research Square · 2023

Authors’ contributions

MSA and LO conceived and designed the study with inputs from CGO; and performed statistical analysis with additional input from BG. All authors had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of data analysis. MSA and CGO contributed to acquisition, analysis, and interpretation of data; and drafted the manuscript with critical revision from LO and BG. All authors read and approved the final manuscript.

✉ calleb.onyango@yahoo.com
https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License, which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.Fogarty International Center of the National Institute of Health (NIH)D43TW011306National Institute of Mental Health (NIMH)

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T06:07:01.801738+00:00

DOI: 10.21203/rs.3.rs-3286937/v1 · PMC10543430